Guru Ownership Trend
Guru Analysis for Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $71.2 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $18.04 M net inflow during the quarter.
Recent activity highlights Chuck Royce who opened a new position. Conversely, Ken Fisher reduced exposure by 7.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Kura Oncology, Inc. (KURA)
Major holders include Cliff Asness ($34.3 M), Renaissance Technologies (RenTech) ($18.25 M), Ken Fisher ($6.87 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 6.07 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $18.04 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KURA. The total reported sell value was $541,578.09.
Yes, 1 managers opened new positions in KURA, and 2 increased their existing holdings. The total reported buy value was $18.58 M.